PWTYX
Price
$48.96
Change
+$0.12 (+0.25%)
Updated
May 8 closing price
Net Assets
205.66M
RLBCX
Price
$34.14
Change
+$0.05 (+0.15%)
Updated
May 8 closing price
Net Assets
234.05B
Ad is loading...

PWTYX vs RLBCX

Header iconPWTYX vs RLBCX Comparison
Open Charts PWTYX vs RLBCXBanner chart's image
UBS US Allocation P
Price$48.96
Change+$0.12 (+0.25%)
VolumeN/A
Net Assets205.66M
American Funds American Balanced R3
Price$34.14
Change+$0.05 (+0.15%)
VolumeN/A
Net Assets234.05B
PWTYX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PWTYX vs. RLBCX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PWTYX is a Buy and RLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 234B vs. PWTYX (206M). PWTYX pays higher dividends than RLBCX: PWTYX (1.89) vs RLBCX (1.70). PWTYX was incepted earlier than RLBCX: PWTYX (32 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than PWTYX (0.77). PWTYX is a more actively managed with annual turnover of: 58.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than PWTYX: RLBCX (250) vs PWTYX (2000000). RLBCX annual gain was more profitable for investors over the last year : 4.39 vs. PWTYX (-0.43). RLBCX return over 5 years is better than : 34.93 vs. PWTYX (11.49).
PWTYXRLBCXPWTYX / RLBCX
Total Expense Ratio0.770.8987%
Annual Report Gross Expense Ratio0.770.8987%
Fund Existence32 years23 years-
Gain YTD-3.3450.323-1,035%
Front LoadN/AN/A-
Min. Initial Investment2000000250800,000%
Min. Initial Investment IRAN/AN/A-
Net Assets206M234B0%
Annual Yield % from dividends1.891.70112%
Returns for 1 year-0.434.39-10%
Returns for 3 years8.4920.9541%
Returns for 5 years11.4934.9333%
Returns for 10 years27.6448.0258%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN12.780.49
+3.99%
Viridian Therapeutics
PCB20.170.49
+2.49%
PCB Bancorp
AB40.90-0.17
-0.41%
AllianceBernstein Holding LP
BCTX3.18-0.09
-2.75%
Briacell Therapeutics Corp NEW
NTR54.75-1.87
-3.30%
Nutrien Ltd